CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
Luo J, Chimge NO, Zhou B, Flodby P, Castaldi A, Firth AL, Liu Y, Wang H, Yang C, Marconett CN, Crandall ED, Offringa IA, Frenkel B, Borok Z.
Luo J, et al. Among authors: zhou b.
Int J Cancer. 2018 Dec 15;143(12):3169-3180. doi: 10.1002/ijc.31734. Epub 2018 Oct 16.
Int J Cancer. 2018.
PMID: 30325015
Free PMC article.